354 related articles for article (PubMed ID: 7595220)
1. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines.
Sad S; Mosmann TR
J Exp Med; 1995 Nov; 182(5):1505-15. PubMed ID: 7595220
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-deficient CD8+ Tc1 cells induced by IL-4: retained inflammation and perforin and Fas cytotoxicity but compromised long term killing of tumor cells.
Sad S; Li L; Mosmann TR
J Immunol; 1997 Jul; 159(2):606-13. PubMed ID: 9218575
[TBL] [Abstract][Full Text] [Related]
3. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo.
Erdmann AA; Gao ZG; Jung U; Foley J; Borenstein T; Jacobson KA; Fowler DH
Blood; 2005 Jun; 105(12):4707-14. PubMed ID: 15746085
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization and modulation of cytokine production by CD8+ T cells from human immunodeficiency virus-infected individuals.
Maggi E; Manetti R; Annunziato F; Cosmi L; Giudizi MG; Biagiotti R; Galli G; Zuccati G; Romagnani S
Blood; 1997 May; 89(10):3672-81. PubMed ID: 9160672
[TBL] [Abstract][Full Text] [Related]
5. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.
Croft M; Carter L; Swain SL; Dutton RW
J Exp Med; 1994 Nov; 180(5):1715-28. PubMed ID: 7525836
[TBL] [Abstract][Full Text] [Related]
6. CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions.
Li L; Sad S; Kägi D; Mosmann TR
J Immunol; 1997 May; 158(9):4152-61. PubMed ID: 9126975
[TBL] [Abstract][Full Text] [Related]
7. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
Niedbala W; Wei X; Liew FY
Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
[TBL] [Abstract][Full Text] [Related]
8. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD3-induced anergy in cloned human Th0, Th1, and Th2 cells.
Nguyen DD; Beck L; Spiegelberg HL
Cell Immunol; 1995 Oct; 165(1):153-7. PubMed ID: 7671320
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
[TBL] [Abstract][Full Text] [Related]
11. Single human T cells stimulated in the absence of feeder cells transcribe interleukin-2 and undergo long-term clonal growth in response to defined monoclonal antibodies and cytokine stimulation.
Sunder-Plassmann R; Breiteneder H; Zimmermann K; Strunk D; Majdic O; Knapp W; Holter W
Blood; 1996 Jun; 87(12):5179-84. PubMed ID: 8652831
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF.
Joseph SB; Miner KT; Croft M
Eur J Immunol; 1998 Jan; 28(1):277-89. PubMed ID: 9485207
[TBL] [Abstract][Full Text] [Related]
13. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
Vinay DS; Kwon BS
Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
Selvan RS; Nagarkatti PS; Nagarkatti M
Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
[TBL] [Abstract][Full Text] [Related]
15. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
Wang X; Mosmann T
J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10.
Gerosa F; Paganin C; Peritt D; Paiola F; Scupoli MT; Aste-Amezaga M; Frank I; Trinchieri G
J Exp Med; 1996 Jun; 183(6):2559-69. PubMed ID: 8676077
[TBL] [Abstract][Full Text] [Related]
17. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes.
Vukmanovic-Stejic M; Vyas B; Gorak-Stolinska P; Noble A; Kemeny DM
Blood; 2000 Jan; 95(1):231-40. PubMed ID: 10607707
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
19. The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity.
Kemp RA; Bäckström BT; Ronchese F
Immunology; 2005 Jul; 115(3):315-24. PubMed ID: 15946249
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity.
Sad S; Krishnan L; Bleackley RC; Kägi D; Hengartner H; Mosmann TR
Eur J Immunol; 1997 Apr; 27(4):914-22. PubMed ID: 9130644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
